JAMES YEAGER: Open Payments
NPI 1922630367 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 81 payments from 19 companies in 2025. Trend: 2023 $1,243 · 2024 $1,096 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $366 |
| PFIZER INC. | 11 | $166 |
| Amgen Inc. | 13 | $165 |
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Cepheid | 1 | $110 |
| Astellas Pharma US Inc | 6 | $109 |
| Lilly USA, LLC | 4 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Exact Sciences Corporation | 3 | $51 |
| Novo Nordisk Inc | 3 | $50 |
Products named: QULIPTA, AIRSUPRA, GeneXpert, Veozah, OTEZLA, NURTEC ODT, Kerendia, UBRELVY.
Industry payments across AR — which companies pay providers there.
